Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
Lonza, announced that it has signed an agreement to acquire Redberry SAS (Redberry), an innovative company specializing in rapid microbiology testing solutions using solid-phase cytometry (SPC) ...
The quality of water for pharmaceutical production (purified water, water for injection, and ultrapure water) is quantified and regulated through four parameters – total organic carbon (TOC), ...
Partners also plan to develop fast, easy, load-and-leave microbial testing solutions. Becton Dickinson’s BD Diagnostics and Lonza inked an exclusive licensing and collaboration deal to commercialize ...
The most probable number (MPN) bioburden test method can be a valuable tool for determining bioburden counts when the typical bioburden test methods are problematic on a particular product or when a ...
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...
The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...
Bioburden testing serves a variety of purposes, and the relevance of the data can range from relatively insignificant to extremely critical. Bioburden tests can be used for general tracking or ...
Lonza, announced that it has signed an agreement to acquire Redberry SAS (Redberry), a company specializing in rapid microbiology testing solutions using solid-phase cytometry (SPC) technology. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results